Search

Rare earth vanadates are promising for solar‐to‐fuel conversions, yet their photocatalytic efficiency is limited by the substantial recombination of photo‐generated carriers. Constructing heterojunctions is recognized as an effective approach to improving charge carrier separation in vanadates. Nonetheless, inefficient charge transfer often results from the poor quality of interfaces and non‐directional charge transfer within these heterojunctions. Herein, an S‐scheme AgInS2/CeVO4@Biocharx (AIS/CV@Cx) heterojunction photocatalyst is designed and synthesized through a straightforward freeze‐drying and calcination three‐step process, aimed at photocatalytic co‐production of xylonic acid and carbon monoxide (CO) from xylose. The AIS/CV@C2 heterojunction achieves an optimal yield of 67.74% for xylonic acid and a CO release of 29.76 µmol from xylose. The enhanced photocatalytic performance of the AIS/CV@C2 heterojunction is attributed to three key factors: I) the high‐quality interface and intimate contact within the AIS/CV@C2 heterojunction significantly reduce undesirable carriers recombination, II) the staggered band structures and directed carriers transfer in the AIS/CV@C2 heterojunction notably improve spatial carriers separation/migration, and III) the incorporation of biochar boosts the conductivity of the AIS/CV@C2 heterojunction. This work presents a straightforward yet effective method for fabricating vanadate heterojunctions, highlighting the importance of quality interfacial contact and directed charge transfer in amplifying photocatalytic performance. [ABSTRACT FROM AUTHOR]

Effective bone regeneration through tissue engineering requires a combination of osteogenic progenitors, osteoinductive biofactors and biocompatible scaffold materials. Mesenchymal stem cells (MSCs) represent the most promising seed cells for bone tissue engineering. As multipotent stem cells that can self-renew and differentiate into multiple lineages including bone and fat, MSCs can be isolated from numerous tissues and exhibit varied differentiation potential. To identify an optimal progenitor cell source for bone tissue engineering, we analyzed the proliferative activity and osteogenic potential of four commonly-used mouse MSC sources, including immortalized mouse embryonic fibroblasts (iMEF), immortalized mouse bone marrow stromal stem cells (imBMSC), immortalized mouse calvarial mesenchymal progenitors (iCAL), and immortalized mouse adipose-derived mesenchymal stem cells (iMAD). We found that iMAD exhibited highest osteogenic and adipogenic capabilities upon BMP9 stimulation in vitro , whereas iMAD and iCAL exhibited highest osteogenic capability in BMP9-induced ectopic osteogenesis and critical-sized calvarial defect repair. Transcriptomic analysis revealed that, while each MSC line regulated a distinct set of target genes upon BMP9 stimulation, all MSC lines underwent osteogenic differentiation by regulating osteogenesis-related signaling including Wnt, TGF-β, PI3K/AKT, MAPK, Hippo and JAK-STAT pathways. Collectively, our results demonstrate that adipose-derived MSCs represent optimal progenitor sources for cell-based bone tissue engineering., Competing Interests: The authors declare they have no competing interests., (© 2023 The Authors.)